KRMD - NASDAQ
KORU Medical Systems, Inc.
$4.14
+3.5%KORU Medical Systems, Inc. designs, manufactures, and markets portable medical devices primarily for the ambulatory infusion market in the United States and internationally. It offers mechanical infusion product comprising the FREEDOM infusion systems that include the FREEDOM60 syringe driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company also provides education and training materials to clinicians, patients, and patient advocates. It sells its products through direct sales and medical device distributors, as well as online. KORU Medical Systems, Inc. was incorporated in 1980 and is headquartered in Chester, New York.
At a Glance
Live SnapshotKORU Medical Systems, Inc. Profit Bridge
Profitability Analysis
Gross Margin
Exceptional pricing power and cost management. The company retains over half of revenue after direct costs.
Operating Margin
Operating losses indicate the core business is unprofitable. Requires restructuring or revenue growth.
Net Profit Margin
Net losses indicate the company is burning cash. Sustainability depends on path to profitability.
Profitability Insight
Margin squeeze alert: Healthy gross margins but weak operating margins suggest excessive operating expenses. Cost optimization could unlock significant value.
KORU Medical Systems, Inc. Income Statement
KRMD • NASDAQ
| KORU Medical Systems, Inc. Income Statement | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Feb 2017 | Feb 2016 | Feb 2015 | Feb 2014 | Feb 2013 | Feb 2012 | Feb 2011 | Feb 2010 | Feb 2009 | Feb 2008 | Feb 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
REVENUE | ||||||||||||||||||||
41.1M | 33.6M | 28.5M | 27.9M | 23.5M | 24.2M | 23.2M | 17.4M | 16M | 12.3M | 12.2M | 11.2M | 8.7M | 7.8M | 6.4M | 4.9M | 3.8M | 3.4M | 2.3M | 1.7M | |
GROSS PROFIT | ||||||||||||||||||||
(16.3M) | (12.3M) | (11.8M) | (12.5M) | (9.7M) | (9.2M) | (8.3M) | (6.5M) | (6.5M) | (4.7M) | (4.6M) | (4.6M) | (3.4M) | (2.8M) | (2.3M) | (1.7M) | (1.3M) | (1.2M) | (900K) | (663.5K) | |
24.8M | 21.3M | 16.7M | 15.4M | 13.8M | 14.9M | 14.9M | 10.8M | 9.5M | 7.6M | 7.6M | 6.7M | 5.3M | 4.9M | 4.1M | 3.3M | 2.5M | 2.2M | 1.4M | 1.1M | |
OPERATING INCOME | ||||||||||||||||||||
(27.8M) | (27.8M) | (27M) | (26.1M) | (20.8M) | (16.2M) | (10.9M) | (8.7M) | (8M) | (8.3M) | (6.4M) | (5.5M) | (4.3M) | (3.9M) | (2.8M) | (2.1M) | (1.8M) | (1.4M) | (1.3M) | (1.1M) | |
(23.4M) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (9.8M) | (8.2M) | (7.9M) | (7.8M) | (5.9M) | (4.8M) | (3.9M) | (3.5M) | (2.7M) | (2M) | (1.7M) | (1.3M) | (1.1M) | (993.4K) | |
(4.4M) | (5.3M) | (5.7M) | (5M) | (2.5M) | (1.3M) | (740.5K) | (241.1K) | (60.7K) | (237.5K) | (207.3K) | (468.2K) | (218.2K) | (147.6K) | (90.3K) | (35.5K) | (27.9K) | (22.4K) | (59.9K) | (42K) | |
-3M | -6.4M | -10.3M | -10.8M | -7M | -1.3M | 585.7K | 1.2M | 1.5M | -736.3K | 1.2M | 1.1M | 1M | 1.1M | 1.3M | 1.2M | 721.5K | 779K | 193.5K | -22.1K | |
PRE-TAX INCOME | ||||||||||||||||||||
(0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (1.9K) | (3.4K) | (512.0) | (4.5K) | (28.3K) | (31.5K) | (36.4K) | (47.5K) | (51.7K) | (0.0) | (0.0) | |
293.4K | 444.6K | 561.3K | 145.6K | 13.1K | 42.4K | 80.7K | 28.1K | 0.0 | 1.1K | -3.4K | 5.1K | 2.9K | -20.2K | -18.7K | -27.7K | -46.2K | -51.7K | 0.0 | 0.0 | |
(0.0) | (22.5M) | (21.2M) | (21.2M) | (18.3M) | (14.9M) | (0.0) | (0.0) | (0.0) | (0.0) | -9.2K | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | |
356.4K | 382.5K | 496.4K | 105.7K | 665.1K | 60.5K | 110.7K | 12.4K | 85.2K | -40.4K | -38.8K | -72.9K | 2.8K | -24.3K | -8K | -1.7K | -59.1K | -54.2K | -193.5K | -232.6K | |
-2.6M | -6.1M | -9.8M | -10.7M | -6.4M | -1.2M | 696.4K | 1.2M | 1.6M | -776.7K | 1.1M | 1.1M | 1M | 1M | 1.3M | 1.2M | 662.5K | 724.9K | 0.0 | -254.7K | |
NET INCOME | ||||||||||||||||||||
(21.9K) | (2.9K) | (4M) | -2M | -1.8M | (17.8K) | (132.1K) | (266.4K) | (483.1K) | -241.7K | (359.7K) | (321.4K) | (307K) | (312.3K) | (465.3K) | (489K) | -227K | -306K | (196K) | (0.0) | |
-2.6M | -6.1M | -13.7M | -8.7M | -4.6M | -1.2M | 564.3K | 910.6K | 1.1M | -535K | 782.9K | 753.1K | 703.4K | 725.8K | 815.9K | 704.1K | 889.4K | 1M | -2.5K | -254.7K |
SEC Filings
KRMD - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
8-K 8-K 2026 N/A | May 21, 2026 | May 19, 2026 | 2026 | |
10-Q 10-Q 2026 Q1 Q1 | May 06, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 06, 2026 | May 06, 2026 | 2026 | |
DEF 14A DEF 14A 2025 N/A | April 09, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | April 03, 2026 | March 30, 2026 | 2026 | |
8-K 8-K 2026 N/A | March 16, 2026 | March 12, 2026 | 2026 | |
10-K 10-K 2025 FY FY | March 12, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | March 12, 2026 | March 12, 2026 | 2026 | |
8-K 8-K 2026 N/A | February 11, 2026 | February 05, 2026 | 2026 | |
8-K 8-K 2026 N/A | January 12, 2026 | January 12, 2026 | 2026 |
Related Guides
Continue your KRMD research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.